Literature DB >> 17469353

[Outpatient chemotherapy of an advanced or metastatic colorectal cancer].

Takeo Sato1, Yukihito Kokuba, Heita Ozawa, Kazuhiko Hatate, Takatoshi Nakamura, Wataru Onosato, Atsushi Ihara, Masahiko Watanabe.   

Abstract

We report the outpatient chemotherapy of an advanced or metastatic colorectal cancer. From April 2005 to May 2006, 50 patients were treated with FOLFIRI or FOLFOX in our hospital. Forty five patients (90%) had an intravenous catheter and a port for the chemotherapy, 23 patients (46%) were treated at the outpatient booths. We used the clinical pathway in chemotherapy for patients and co-medical roles. We were not experiencing emergency admission of side effects. Outpatient chemotherapy utilizing FOLFIRI or FOLFOX for advanced or metastatic colorectal cancer can be enforced safely by using the clinical pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17469353

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer.

Authors:  Eun-Hye Joo; Sun-Young Rha; Joong Bae Ahn; Hye-Young Kang
Journal:  Support Care Cancer       Date:  2010-05-23       Impact factor: 3.603

2.  Similar Quality of Life and Safety in Patients Receiving Inpatient or Outpatient Chemotherapy: A Focus on Esophageal Squamous Cell Carcinoma.

Authors:  Yen-Hao Chen; Su-Wei Chen; Hung-I Lu; Chien-Ming Lo; Shau-Hsuan Li
Journal:  Healthcare (Basel)       Date:  2020-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.